Similar to our finding that gemR cells have relatively high levels of CDC25B, upregulation of this protein by PI3K-Akt-mTOR inhibitors is associated with resistance to this family of inhibitors in AML[46]. The gene discussed is MTOR; the disease is acute myeloid leukemia.